FABP7 and Dravet syndrome: This suggests that the transactivation of the FABP7 (6q22-23) gene promoter is due to PKNOX1 (21q.22.3) overexpression and may be indirectly related to DS neuropathogenesis by altering the expression of other genes (Sánchez-Font et al., 2003).